Herr, Annika; Suppliet, Moritz - 2012
steer drug demand and to control expenses. For example, they introduce reference pricing or tiered co-payments to enhance … drug substitution and competition. Since 2006, Germany follows an innovative approach by differentiating drug co … potential reductions in co-payments. We refer to the latter result as the "co-payment exemption paradox." Our competition proxy …